Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immediate-release versus extended-release tacrolimus in lung transplant recipients
NL-OMON58937Phase 3Completed
- Sponsor
- University Medical Center Groningen
- Start
- Jan 2025
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of tacrolimus in lung transplantation (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Kidney function. Started Jan 2025; status: completed.
02
Drugs
tacrolimus
03
Conditions
lung transplantation
Beyond the preview
Go deeper on NL-OMON58937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58937.